BioCanRx Director of Biotherapeutics Manufacturing Operations, Dr. Jennifer Quizi, was recently featured in an article from The Ottawa Citizen about a new program that’s providing hands-on training to improve Canada’s biomanufacturing capacity. Read more: https://ottawacitizen.com/news/local-news/the-right-stuff
Category: News
Carl H. June to be Keynote Speaker at 2021 Summit4CI!
BioCanRx is pleased to announce Dr. Carl H. June as our distinguished keynote speaker for the 2021 Summit for Cancer Immunotherapy taking place November 20-22, 2021. Dr. June is the Richard W. Vague Professor in Immunotherapy, Director of the Center for Cellular Immunotherapies and Director of the Parker Institute for Cancer Immunotherapy in the… Read more »
Where Are They Now: Nicole Forbes
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Making an obvious target attainable
By Heather Blumenthal For Rob Holt and Simon Turcotte, pancreatic cancer was an obvious target. First, because the need is so great. Pancreatic cancer was the fourth-leading cause of cancer death in 2019. And, Dr. Holt (co-director of the BC Cancer Immunotherapy Program) suspects, it will be making its way further up… Read more »
CSA Member Profile – Niya Chari
How did you get involved with the Canadian Breast Cancer Network? What attracted you to the organization? Like many Canadians, I have had loved ones go through a cancer diagnosis. I have seen first-hand how challenging and devastating this disease can be. But I have also seen how pivotal access to early detection and… Read more »
OHRI Interview Study Seeking Researcher Participation: Patient Engagement in Preclinical Research
This research team is interested in learning more about patient engagement team member roles, activities, important aspects of patient-researcher partnerships, and what makes working as a team easy or difficult. As part of this objective, they are still seeking researchers who are able to participate in one-on-one interviews. Full details here.
BioCanRx Summer Students Tell All
It’s been a summer unlike any other, and the 13 undergraduate students who embarked on a BioCanRx-funded research internship in cancer immunotherapeutics during a global pandemic have likely had an experience like no other. Some have been able to do work in the lab, while others chose to defer their internships. Whatever the circumstances, we… Read more »
From “what if” to “what is”
By Heather Blumenthal It’s just a small change from “what if” to “what is” – just change that “f” to an “s.” But that small change could make a world of difference to people with cancer. What if you could deliver just one product, in this case one cancer-killing (or oncolytic) virus, to… Read more »
Where Are They Now? Q&A with Former BioCanRx HQPs
At BioCanRx, we are incredibly proud of our HQP and their dedication to cancer immunotherapy research. Whether they are working on viruses in the lab or examining the socioeconomic barriers to adopting certain treatments in Canada, each one plays a unique role in strengthening our network and expertise in immunotherapy. BioCanRx is invested in… Read more »
Ottawa at Work: A clinical trial right here in Ottawa aims to protect cancer patients from COVID-19
CFRA radio host Leslie Roberts speaks with Dr. Rebecca Auer, study lead, BioCanRx network investigator, surgical oncologist and Director of Cancer Research at The Ottawa Hospital and associate professor at the University of Ottawa about her new research that aims to protect cancer patients from COVID-19. Listen here
